Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond

1. Beyond Cytoreductive Surgery and HIPEC

   1. Front Matter

      Pages 447-447

      PDF

   2. Cytoreductive Surgery and HIPEC in the Elderly

      • Joseph Dux, Almog Ben-Yaacov, Aviram Nissan

      Pages 449-459

   3. Quality of Life Issues in Patients Undergoing Cytoreductive Surgery and HIPEC

      • Julianna P. Englisch, Andreas Brandl, Ute Goerling, Beate Rau

      Pages 461-467

   4. New Treatment Modalities for the Management of Peritoneal Metastases

      • Aditi Bhatt, Akash Mehta

      Pages 469-506

   5. Registries and Collaborative Groups in Peritoneal Surface Oncology

      • Aditi Bhatt, Kiran K. Turaga

      Pages 507-526

   6. Locoregional and Palliative Therapies for Patients with Unresectable Peritoneal Metastases

      • Ninad Katdare, Robin Prabhu, Aditi Bhatt

      Pages 527-559

   7. Training Programs for Cytoreductive Surgery and HIPEC

      • Beate Rau, Maria Clara Arroyave, Dusan Klos

      Pages 561-568

2. Back Matter

   Pages 569-580

   PDF

The widespread acceptance among the oncology community at large of cytoreductive surgery and HIPEC as a potentially curative treatment for peritoneal metastases has paved the way for innovative new therapies that could benefit a larger proportion of patients. Much has been and continues to be published on this subject.

This book provides comprehensive reviews on the various aspects of managing peritoneal metastases. The authors highlight essential practical issues that surgical oncologists encounter in their day-to-day practice, and try to before provide evidence based answers to address them. All chapters were written and/or reviewed by leading experts in this field.

• Peritoneal surface malignancies
• Cytoreductive surgery
• HIPEC
• EPIC
• Malignant peritoneal mesothelioma
• surgical oncology
• abdominal surgery

• Department of Surgical Oncology, Fortis Hospital, Bangalore, India

  Aditi Bhatt

''Dr. Aditi Bhatt is a Surgical oncologist specializing in the management of peritoneal surface malignancies. She has done her surgical oncology training from the Gujarat Cancer Research Institute in Ahmedabad, India and has further pursued a fellowship in peritoneal surface malignancies at Institut Gustave Roussy, Paris, France. She has been pursuing peritoneal surface oncology as a speciality for seven years. She was associate editor with Dr. Paul H. Sugarbaker for the special issue of the Indian Journal of Surgical Oncology on peritoneal surface malignancies in 2016. Dr. Aditi is currently involved in developing a robust system for collection and publication of Indian data pertaining to the management of peritoneal metastases and conducting multi-institutional studies.  Here specific areas of interest are pseudomyoma peritonei and other rare peritoneal tumors and ovarian cancer.'

Policies and ethics